華宇藥 (6621) 月營收分析比較圖

華宇藥 (6621) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2024/03	7,320	8,216	9.9%	-10.9%	23,547	25,619	-8.1%
2024/02	6,660	7,312	-30.4%	-8.9%	16,227	17,403	-6.8%
2024/01	9,567	10,091	-0.4%	-5.2%	9,567	10,091	-5.2%
2023/12	9,606	15,547	13%	-38.2%	103,222	128,107	-19.4%
2023/11	8,499	12,446	-1.2%	-31.7%	93,616	112,560	-16.8%
2023/10	8,600	11,983	7%	-28.2%	85,117	100,114	-15%
2023/09	8,036	12,182	-17.2%	-34%	76,516	88,131	-13.2%
2023/08	9,710	11,269	19.6%	-13.8%	68,480	75,948	-9.8%
2023/07	8,118	10,206	-12.3%	-20.5%	58,770	64,679	-9.1%
2023/06	9,255	8,031	14.6%	15.2%	50,652	54,473	-7%
2023/05	8,079	8,402	4.9%	-3.8%	41,397	46,442	-10.9%
2023/04	7,698	9,997	-6.3%	-23%	33,318	38,040	-12.4%
2023/03	8,216	10,322	12.4%	-20.4%	25,619	28,043	-8.6%
2023/02	7,312	7,135	-27.5%	2.5%	17,403	17,721	-1.8%
2023/01	10,091	10,586	-35.1%	-4.7%	10,091	10,586	-4.7%
2022/12	15,547	11,675	24.9%	33.2%	128,107	105,386	21.5%
2022/11	12,446	10,780	3.9%	15.4%	112,560	93,711	20.1%
2022/10	11,983	8,424	-1.6%	42.2%	100,114	82,931	20.7%
2022/09	12,182	8,701	8.1%	40%	88,131	74,506	18.3%
2022/08	11,269	8,864	10.4%	27.1%	75,948	65,806	15.4%
2022/07	10,206	10,907	27.1%	-6.4%	64,679	56,941	13.6%
2022/06	8,031	4,734	-4.4%	69.6%	54,473	46,034	18.3%
2022/05	8,402	9,152	-15.9%	-8.2%	46,442	41,301	12.4%
2022/04	9,997	7,592	-3.1%	31.7%	38,040	32,149	18.3%
2022/03	10,322	7,346	44.7%	40.5%	28,043	24,557	14.2%
2022/02	7,135	6,941	-32.6%	2.8%	17,721	17,211	3%
2022/01	10,586	10,270	-9.3%	3.1%	10,586	10,270	3.1%
2021/12	11,675	11,353	8.3%	2.8%	105,386	138,635	-24%
2021/11	10,780	10,614	28%	1.6%	93,711	127,282	-26.4%
2021/10	8,424	10,745	-3.2%	-21.6%	82,931	116,669	-28.9%
2021/09	8,701	9,372	-1.8%	-7.2%	74,506	105,923	-29.7%
2021/08	8,864	12,628	-18.7%	-29.8%	65,806	96,552	-31.8%
2021/07	10,907	14,873	130.4%	-26.7%	56,941	83,924	-32.2%
2021/06	4,734	8,975	-48.3%	-47.3%	46,034	69,051	-33.3%
2021/05	9,152	17,570	20.5%	-47.9%	41,301	60,077	-31.3%
2021/04	7,592	10,503	3.3%	-27.7%	32,149	42,507	-24.4%